https://www.onclive.com/view/dr-tabernero-on-the-efficacy-of-bevacizumab-plus-tas-102-in-refractory-mcrc
0
0
1/21/23 at 11:34pm
Organization
OncLive
45 words
0
Comments
Josep Tabernero, MD, PhD, discusses findings from the phase 3 SUNLIGHT trial investigating the combination of bevacizumab plus trifluridine/tipiracil vs TAS-102 alone in patients with refractory metastatic colorectal cancer.
You are the first to view
Create an account
or login to join the discussion